Stay updated with breaking news from Director jerome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PTC Therapeutics (NASDAQ:PTCT – Free Report) had its price objective lifted by The Goldman Sachs Group from $18.00 to $32.00 in a report published on Tuesday, Benzinga reports. The Goldman Sachs Group currently has a sell rating on the biopharmaceutical company’s stock. Several other analysts also recently commented on the stock. Citigroup raised their target […] ....
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have been given an average rating of “Hold” by the fourteen analysts that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and four have issued a buy recommendation on […] ....
Piper Sandler cut shares of Itron (NASDAQ:ITRI – Free Report) from an overweight rating to a neutral rating in a research report sent to investors on Tuesday, Marketbeat.com reports. They currently have $109.00 price target on the scientific and technical instruments company’s stock. Other equities research analysts have also recently issued research reports about the […] ....
PTC Therapeutics (NASDAQ:PTCT – Free Report) had its target price hoisted by JPMorgan Chase & Co. from $43.00 to $53.00 in a research report released on Tuesday morning, Benzinga reports. They currently have an overweight rating on the biopharmaceutical company’s stock. A number of other brokerages also recently weighed in on PTCT. Cantor Fitzgerald reissued […] ....
Citigroup Increases PTC Therapeutics (NASDAQ:PTCT) Price Target to $26.00 dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.